Allergan Breast Implant Lawsuit Review Nationwide!
**WE HAVE WON VERDICTS AND/OR SETTLEMENTS OF
OVER 5 BILLION DOLLARS.**
1. Did you ever have Textured Breast Implants and/or Tissue Expanders on the Allergan Recall list below?
|
Natrelle Saline breast implant styles 168, 363, 468 |
| Natrelle and McGhan 410 breast implant styles LL, LM, LF, LX, ML, MM, MF, MX, FL, FM, FF, FX |
| Natrelle and McGhan 410 Soft Touch breast implant styles LL, LM, LF, LX, ML, MM, MF, MX, FL, FM, FF, FX |
| Natrelle 510 Dual-Gel styles LX, MX, FX |
| Natrelle INSPIRA breast implants, styles TRL, TRLP, TRM, TRF, TRX, TSL, TSLP, TSM, TSF, TSX, TCL, TCLP, TCM, TCF, TCX |
| Natrelle and McGhan Round Gel Implants, styles 110, 110 Soft Touch, 120, 120 Soft Touch |
| Natrelle Komuro breast implants styles KML, KMM, KLL, and KLM |
| Natrelle Ritz Princess breast implant styles RML, RMM, RFL, RFM |
| Natrelle 150 Full Height and Short Height double lumen implants |
| Natrelle 133 tissue expanders with and without suture tabs: styles 133FV, 133MV, 133LV, 133MX, 133SX, 133SV, T-133FV, T-133MV, T-133LV, T-133MX, T-133SX, T-133SV, 133FV-T, 133MV-T, 133LV-T, 133MX-T, 133SX-T, 133SV-T |
|
Natrelle 133 Plus tissue expander styles 133P-FV, 133P-MV, 133P-LV, 133P-MX, 133P-SX, |
2. Subsequent to your implants did you develop anaplastic large cell lymphoma (BIA-ALCL)?
If yes to these questions, please contact us or fill out the free case review form above.
We believe these cases deserve substantial compensation.
We will never charge you a dime unless we actually make a monetary recovery for you.
The FDA requests to Allergan for a voluntary recall.
The U.S. Food and Drug Administration took significant action on July 24, 2019 to protect women from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) by requesting that Allergan, the manufacturer of a specific type of textured implant, recall specific models of its textured breast implants from the U.S. market due to the risk of BIA-ALCL. Following the FDA’s request, Allergan moved forward with a worldwide recall of their BIOCELL textured breast implant products, including: Natrelle Saline-Filled breast implants, Natrelle Silicone-Filled breast implants, Natrelle Inspira Silicone-Filled breast implants, and Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants. The recall also included tissue expanders used by patients prior to breast augmentation or reconstruction, including Natrelle 133 Plus Tissue Expander and Natrelle 133 Tissue Expander with Suture Tabs. This recall helps ensure that unused products are also removed from suppliers and doctors’ offices.
The FDA provided a new total of 573 unique cases of BIA-ALCL of which 481 are attributed to Allergan implants. Of the 33 patients deaths, the FDA reported that 12 of 13 patients for which the manufacturer of the implant is known are confirmed to have an Allergan breast implant at the time of their BIA-ALCL diagnosis.
Lymphoma Cancer
BIA-ALCL is a type of non-Hodgkin’s lymphoma—a cancer of the immune system rather than breast cancer. BIA-ALCL forms within the scar tissue and fluid that surround the implant.
Researchers have not yet been able to explain the mechanism behind the link between the macro-textured implants and the lymphoma condition.
The FDA did not currently advise patients with Allergan BIOCELL textured breast implants to have their implants removed unless they show symptoms. Symptoms of BIA-ALCL can included persistent pain or swelling close to the breast implant and any other noticeable visible changes in the region.
Physicians can diagnose BIA-ALCL through a physical exam with an assessment of fluid and tissue in the implant area and imaging techniques. The FDA did recommend that anyone who is diagnosed with BIA-ALCL should consult a surgeon to have their implants and the surrounding scar tissue removed. Some cases will most likely require chemotherapy and/or radiation treatment.
Lawsuits have been filed and are increasing.
We believe that Allergan
- Knew or should have known about the serious design problems associated with these Textured Breast Implants and Tissue Expanders;
- Failed to adequately research these Textured Breast Implants and Tissue Expanders;
- Failed to warn about the risk of complications from the Textured Breast Implants and Tissue Expanders;
- Misrepresented the safety of the Textured Breast Implants and Tissue Expanders; and
- Failed to promptly and properly report the results of post-marketing studies that were required by the FDA.
Our team has been involved in Breast implant cases for over 25 years fighting companies like Dow, Bristol Meyers, Mentor, and Johnson and Johnson. We have decades of experience in battling large companies such as Allergan, and we would welcome the opportunity to help you or a loved one if you have developed cancer from these Allergan Textured Breast Implants and/or Tissue Expanders.
Deadline?
There is a deadline for filing any Allergan lawsuit case. Accordingly, if you do not file your claim by the deadline you will lose your right to recover any money at all. Cliff Roberts can tell you the specific deadline in your case.
It is very important that you take action now. Please e-mail us the short case review form. Our evaluation is free and confidential.
Click here for a free case review
**Roberts Law Office has joined forces with the prestigious Law Firm of Fleming, Nolen & Jez L.L.P. in Houston, Texas in an effort to maximize our lawsuit efforts and resources. Every case must be evaluated on its own merits and past success does not guarantee future recovery.**